IRIS
Chiarito, Mauro
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.658
AS - Asia 2.781
EU - Europa 972
SA - Sud America 571
Continente sconosciuto - Info sul continente non disponibili 132
AF - Africa 82
OC - Oceania 5
Totale 9.201
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.485
SG - Singapore 1.564
CN - Cina 575
BR - Brasile 468
IT - Italia 294
VN - Vietnam 274
FI - Finlandia 154
DE - Germania 118
IE - Irlanda 98
CA - Canada 89
IN - India 79
HK - Hong Kong 63
GB - Regno Unito 61
FR - Francia 51
SE - Svezia 44
AR - Argentina 37
BD - Bangladesh 34
MX - Messico 33
NG - Nigeria 32
NL - Olanda 32
TR - Turchia 27
ID - Indonesia 24
IQ - Iraq 24
PL - Polonia 15
RU - Federazione Russa 15
JP - Giappone 14
CR - Costa Rica 12
PY - Paraguay 12
UA - Ucraina 12
CO - Colombia 11
ES - Italia 11
MA - Marocco 11
VE - Venezuela 11
CL - Cile 10
SA - Arabia Saudita 10
EC - Ecuador 9
AZ - Azerbaigian 8
KE - Kenya 8
MY - Malesia 8
ZA - Sudafrica 8
PE - Perù 7
PK - Pakistan 7
TH - Thailandia 7
BE - Belgio 6
EG - Egitto 6
JM - Giamaica 6
RO - Romania 6
TW - Taiwan 6
AT - Austria 5
BO - Bolivia 5
BY - Bielorussia 5
DZ - Algeria 5
GR - Grecia 5
GT - Guatemala 5
HN - Honduras 5
IL - Israele 5
JO - Giordania 5
KZ - Kazakistan 5
LT - Lituania 5
AE - Emirati Arabi Uniti 4
AU - Australia 4
BA - Bosnia-Erzegovina 4
CZ - Repubblica Ceca 4
DO - Repubblica Dominicana 4
KG - Kirghizistan 4
OM - Oman 4
PH - Filippine 4
TN - Tunisia 4
UZ - Uzbekistan 4
CU - Cuba 3
EE - Estonia 3
HU - Ungheria 3
IR - Iran 3
NO - Norvegia 3
NP - Nepal 3
PA - Panama 3
PR - Porto Rico 3
PT - Portogallo 3
RS - Serbia 3
TT - Trinidad e Tobago 3
AL - Albania 2
CH - Svizzera 2
CY - Cipro 2
GE - Georgia 2
HR - Croazia 2
LB - Libano 2
LV - Lettonia 2
SN - Senegal 2
SV - El Salvador 2
SY - Repubblica araba siriana 2
UG - Uganda 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AF - Afghanistan, Repubblica islamica di 1
AM - Armenia 1
AO - Angola 1
BB - Barbados 1
BG - Bulgaria 1
BH - Bahrain 1
BZ - Belize 1
CW - ???statistics.table.value.countryCode.CW??? 1
Totale 9.055
Salva come PNG Salva come JPEG
Città #
Singapore 675
San Jose 558
Ashburn 449
The Dalles 248
Shanghai 240
Dallas 202
Chandler 193
Council Bluffs 184
New York 162
Helsinki 153
Beijing 145
Boardman 118
Los Angeles 117
Wilmington 109
Milan 104
Dublin 97
Santa Clara 94
Ho Chi Minh City 87
Hanoi 57
Hong Kong 54
San Mateo 50
São Paulo 48
Chicago 45
Phoenix 38
Pune 38
Benin City 32
Buffalo 30
Rome 29
Munich 28
Princeton 28
Brooklyn 24
Lawrence 23
Seattle 22
Falkenstein 21
Ann Arbor 20
Toronto 20
Amsterdam 19
Montreal 18
Charlotte 16
Leawood 16
Orem 16
Brasília 15
Woodbridge 15
Naples 14
Warsaw 14
Da Nang 13
Fairfield 13
Haiphong 13
Curitiba 12
Atlanta 11
Frankfurt am Main 11
Paris 11
Turin 11
Denver 10
Hillsboro 10
Philadelphia 10
Rio de Janeiro 10
San José 10
Stockholm 10
Abbeville 9
Boston 9
Cologno Monzese 9
Columbus 9
Houston 9
Miami 9
San Diego 9
San Francisco 9
Assago 8
Chennai 8
Mexico City 8
Tokyo 8
Baghdad 7
Goiânia 7
Johannesburg 7
Kocaeli 7
Kuala Lumpur 7
London 7
Manchester 7
Newark 7
Norwalk 7
Queens 7
Asunción 6
Baku 6
Biên Hòa 6
Brescia 6
Brussels 6
Can Tho 6
Detroit 6
Hải Dương 6
Indianapolis 6
Lima 6
Madison 6
Milwaukee 6
Moscow 6
North Bergen 6
Richmond 6
Tampa 6
Thái Nguyên 6
Abbiategrasso 5
Ankara 5
Totale 5.126
Salva come PNG Salva come JPEG
Nome #
Direct oral anticoagulants in addition to antiplatelet therapy for secondary prevention after acute coronary syndromes: an updated systematic review and meta-analysis 161
Monotherapy with a P2Y12 inhibitor or aspirin for secondary prevention in patients with established atherosclerosis: a systematic review and meta-analysis. 154
Coronary Artery Dissection in Drug-Coated Balloon Angioplasty: Incidence, Predictors, and Clinical Outcomes 140
Cardioprotection with nebivolol in patients undergoing anthracyclines: a randomized placebo-controlled trial 128
Coral Reef Aorta: A Rare Occlusive Disease of the Aorta Complicating Decision Making for Severe Aortic Stenosis Treatment. 119
Continuation versus discontinuation of ACE inhibitors or angiotensin II receptor blockers in COVID-19: Effects on blood pressure control and mortality 115
Acute coronary syndrome in a patient with a residual aortic dissection flap after supracoronary aortic replacement: the role of intravascular ultrasound 114
Early detection of elevated cardiac biomarkers to optimise risk stratification in patients with COVID-19 110
Predicting survival in patients with severe heart failure: risk scores validation in the HELP-HF cohort 105
Prognostic role of mitral regurgitation in patients with advanced heart failure 97
Clinical outcomes with reservoir-based polymer-free amphilimus-eluting stents in real-world patients according to diabetes mellitus and complexity: The INVESTIG8 registry. 96
Impact of Diabetes on Clinical Outcomes After Polymer-Free Amphilimus- and Biolimus-Eluting Stent Implantation 94
Antiplatelet therapy for secondary prevention of cardiovascular disease: challenging the certainties 93
Coronary Revascularisation in Transcatheter Aortic Valve Implantation Candidates: Why, Who, When? Interv Cardiol. 93
The synergy stent in high-bleeding risk patients: why design matters 92
Balloon Versus Self-Expandable Valve for the Treatment of Bicuspid Aortic Valve Stenosis: Insights from the BEAT International Collaborative Registrys 92
Clinical challenges in an unusual setting: ST-elevation in a patient suffering from graft versus host disease, between thrombosis and coronary spasm 92
Impact of High-Density Lipoprotein Levels on Cardiovascular Outcomes of Patients Undergoing Percutaneous Coronary Intervention With Drug-Eluting Stents 89
Drug-Coated balloons vs drug-eluting stents for the treatment of small coronary artery disease: A meta-analysis of randomized trials 88
Implantation of contemporary transcatheter aortic valves in small aortic annuli: the international multicentre TAVI-SMALL 2 registry 87
A Complicated Case of Resistant Hypertension 87
Is Transcatheter Aortic Valve Replacement Superior to Surgical Aortic Valve Replacement? A Meta-Analysis of Randomized Controlled Trials. 87
Characterization of Myocardial Injury in Patients With COVID-19 87
Application of the Academic Research Consortium High Bleeding Risk criteria in patients treated with coronary bioresorbable polymer everolimus-eluting stents: Insights from the POEM trial 84
Cardiac and sudden death after chronic total occlusion percutaneous coronary intervention: Prognostic role of the target vessel 83
Left atrial appendage closure with the Ultraseal device: Initial experience and mid-term follow-up. 82
Nebivolol versus placebo in patients undergoing anthracyclines (CONTROL Trial): rationale and study design 82
P2Y12 vs. aspirin for secondary prevention in patients with established atherosclerosis: a systematic review and Meta-analysis 81
GLP-1-ra and heart failure-related outcomes in patients with and without history of heart failure: an updated systematic review and meta-analysis 81
Long-term prognostic impact of subclinical myocardial dysfunction in patients recovered from COVID-19 79
A contemporary simple risk score for prediction of contrast-associated acute kidney injury after percutaneous coronary intervention: derivation and validation from an observational registry 78
The Placebo Effect on Symptoms, Quality of Life, and Functional Outcomes in Patients With Angina Pectoris: A Meta-analysis of Randomized Placebo-Controlled Trials 77
Lower dose direct oral anticoagulants and improved survival: A combined analysis in patients with established atherosclerosis 77
Safety and efficacy of polymer-free biolimus-eluting stents in all-comer patients: the RUDI-FREE study. 76
Coronary Revascularisation in Transcatheter Aortic Valve Implantation Candidates: Why, Who, When? 75
Direct oral anticoagulants versus Vitamin K antagonists in the treatment of left ventricular thrombosis: a systematic review and meta-analysis 74
Safety and efficacy of polymer-free drug-eluting stents: Amphilimus-eluting Cre8 versus biolimus-eluting biofreedom stents 73
Impact of Race/Ethnicity on Long Term Outcomes After Percutaneous Coronary Intervention with Drug-Eluting Stents 72
[Two-step strategy for the treatment of complex coronary artery disease and aortic stenosis in a patient with severely impaired left ventricular function] 72
Radial versus femoral access for coronary interventions: An updated systematic review and meta-analysis of randomized trials 71
Mitral Valve Stenosis after Transcatheter Aortic Valve Replacement: Case Report and Review of the Literature 70
Impact of anemia on short-term outcomes after TAVR: A subgroup analysis from the BRAVO-3 randomized trial 70
Safety and efficacy of an ultra low dose fluoroscopic protocol for chronic total occlusion recanalization 68
Evolution of antithrombotic therapy in patients undergoing percutaneous coronary intervention: a 40-year journey 68
Impact of complete revascularization on mortality in patients with ST-segment elevation myocardial infarction and multivessel disease: an updated meta-analysis 68
Transcatheter Self-Expandable Valve Implantation for Aortic Stenosis in Small Aortic Annuli The TAVI-SMALL Registry 67
One-year clinical outcome of amphilimus polymer-free drug-eluting stent in diabetes mellitus patients: Insight from the ASTUTE registry (AmphilimuS iTalian mUlticenTre rEgistry) 66
Left main coronary artery disease: when and how to perform PCI? 66
Outcome after percutaneous edge-to-edge mitral repair for functional and degenerative mitral regurgitation: a systematic review and meta-analysis 65
Impact of Small Valve Size on 1-Year Outcomes After Transcatheter Aortic Valve Implantation in Women (from the WIN-TAVI Registry) 65
Weather conditions and incidence of acute coronary syndromes: a large-scale analysis based on national healthcare system administrative data 64
Guided and unguided de-escalation from potent P2Y12 inhibitors among patients with acute coronary syndrome: a meta-analysis 64
Evolution of drug-eluting coronary stents: a back-and-forth journey from the bench-to-bedside 64
Long COVID-19 Cardiac Complications Are Associated With Autoimmunity to Cardiac Self-Antigens Sufficient to Cause Cardiac Dysfunction 64
A sex paradox in clinical outcomes following complex percutaneous coronary intervention 64
Predictors and Clinical Impact of Prosthesis-Patient Mismatch After Self-Expandable TAVR in Small Annuli 63
One-year clinical outcome of biodegradable polymer sirolimus-eluting stent in all-comers population. Insight from the ULISSE registry (ULtimaster Italian multicenter all comerS Stent rEgistry) 63
Early Experience with the Symetis bioprosthesis in real world patients: The Milan Registry 63
One-year clinical outcome of biodegradable polymer sirolimus-eluting stent in diabetic patients: Insight from the ULISSE registry (ULtimaster Italian multicenter all comerS Stent rEgistry) 63
PROGNOSTIC VALUE OF HIGH-SENSITIVITY C-REATIVE PROTEIN AMONG CHRONIC KIDNEY DISEASE PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION 63
One-year clinical outcome of biodegradable polymer sirolimus-eluting stent in patients presenting with acute myocardial infarction: Insight from the ULISSE registry 62
Prognostic Value of Baseline Inflammation in Diabetic and Nondiabetic Patients Undergoing Percutaneous Coronary Intervention 62
Transcatheter aortic valve replacement in patients with end-stage renal disease: Is "better than nothing" good enough? 62
Edge-to-edge percutaneous mitral repair for functional ischaemic and non-ischaemic mitral regurgitation: a systematic review and meta-analysis 62
The Cre8 amphilimus-eluting stent for the treatment of coronary artery disease: safety and efficacy profile 61
Periprocedural outcome in patients undergoing left atrial appendage occlusion with the Watchman FLX device: The ITALIAN-FLX registry 60
The crucial role of the heart valve team in the management of a complex case of multivalvular disease and heart failure 59
Impact of target vessel choice on outcomes following percutaneous coronary intervention in patients with a prior coronary artery bypass graft 59
Prognostic impact of the updated 2018 HFA-ESC definition of advanced heart failure: results from the HELP-HF registry 59
Prognostic value of tricuspid regurgitation 59
Silent cerebral injury after transcatheter aortic valve implantation and the preventive role of embolic protection devices: A systematic review and meta-analysis 59
Midterm and one-year outcome of amphilimus polymer free drug eluting stent in patients needing short dual antiplatelet therapy. Insight from the ASTUTE registry (AmphilimuS iTalian mUlticenTer rEgistry) 58
Risk of cardiac and sudden death with and without revascularisation of a coronary chronic total occlusion 58
Evolving Devices and Material in Transcatheter Aortic Valve Replacement: What to Use and for Whom 58
Perioperative risk and antiplatelet management in patients undergoing non-cardiac surgery within 1 year of PCI 58
Characteristics and outcomes of patients with tricuspid regurgitation and advanced heart failure 58
Efficacy and Safety of P2Y12 Inhibitor Monotherapy After Complex PCI: A Collaborative Systematic Review and Meta-Analysis 57
Prevalence and Impact of High Bleeding Risk in Patients Undergoing Left Main Artery Disease PCI 57
Reversal and removal of oral antithrombotic drugs in patients with active or perceived imminent bleeding 57
Prognostic value of hypochloremia on mortality in patients with heart failure: a systematic review and meta-analysis 57
Drug-eluting stents in diabetic patients: Are we still treading water? 56
Incidence, predictors and clinical impact of permanent pacemaker insertion in women following transcatheter aortic valve implantation: Insights from a prospective multinational registry 56
The mega COMBO collaboration: An individual patient data pooled analysis of patients undergoing PCI with COMBO stent 56
Artificial Intelligence and Cardiovascular Risk Prediction: All That Glitters is not Gold 56
Types of myocardial injury and mid-term outcomes in patients with COVID-19 54
Lopinavir/Ritonavir and Darunavir/Cobicistat in Hospitalized COVID-19 Patients: Findings From the Multicenter Italian CORIST Study 54
Low-Dose Colchicine after Myocardial Infarction 54
Ticagrelor Monotherapy After PCI in High-Risk Patients With Prior MI: A Prespecified TWILIGHT Substudy 54
Preprocedural anemia in females undergoing transcatheter aortic valve implantation: Insights from the WIN-TAVI registry 53
Transcatheter aortic valve replacement in aortic stenosis and cardiac amyloidosis: a systematic review and meta-analysis 53
Panta rhei, also drug eluting stent technology 52
Polymer-free amphilimus-eluting stent versus biodegradable polymer biolimus-eluting stent in patients with and without diabetes mellitus 52
Treating Inflammation Prior to Percutaneous Coronary Intervention: Does the Heart Care? 52
P2Y12 Inhibitor or Aspirin Monotherapy for Secondary Prevention of Coronary Events 51
Clinical burden and predictors of non-cardiovascular mortality and morbidity in advanced heart failure 51
Clinical and prognostic implications of heart failure hospitalization in patients with advanced heart failure 51
Young Patient with Advanced Heart Failure No Longer a Candidate for Heart Transplantation after MitraClip® Procedure 51
Vitamin D and Cardiovascular Diseases: From Physiology to Pathophysiology and Outcomes 51
One-year clinical outcome of biodegradable polymer sirolimus-eluting stent in patients needing short dual antiplatelet therapy. Insight from the ULISSE registry (ULtimaster Italian multicenter all comerS Stent rEgistry) 51
Postoperative Delirium in Individuals Undergoing Transcatheter Aortic Valve Replacement: A Systematic Review and Meta-Analysis 49
Totale 7.284
Salva come PNG Salva come JPEG
Categoria #
all - tutte 58.039
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 58.039
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022125 0 0 0 28 3 1 4 23 11 8 34 13
2022/2023760 54 18 32 96 75 48 16 45 151 106 89 30
2023/2024963 93 87 175 80 37 115 61 62 20 51 84 98
2024/20251.422 32 5 29 24 23 169 86 109 231 353 191 170
2025/20263.961 527 296 214 335 157 211 1.084 197 174 269 170 327
2026/20271.746 291 342 877 236 0 0 0 0 0 0 0 0
Totale 9.201